Loading
Top

Putting the HHS Roadmap into Action

Systemic healthcare change across the country is in the works after the U.S. Department of Health and Human Services (HHS) released its Roadmap for Behavioral Health Integration earlier this year.

Looking ahead to 2023, HHS aims to further address mental health and substance use as part of the country’s overall approach to health care. The Department has already started building upon the roadmap’s three pillars of focus that President Biden shared during his first State of the Union address, and will continue working with many organizations already making a positive impact in the healthcare space.

But how does our work play into all of this? At Cordant, we’re continually working with our partners and clinicians to provide solutions that make treatment for substance use and mental health disorders more accessible and effective. Specifically, here are a few ways our work aligns with the roadmap and its pillars:

Addressing the aim to reduce the technology gap between providers in the Strengthen System Capacity pillar, Cordant offers our Cordant Sentry™ system, a secure, HIPAA-compliant drug testing management system that allows for better coordination of care between government agencies and treatment providers.

Cordant also aims to uphold the Connect Americans to Care pillar of the roadmap by partnering with healthcare providers to offer a managed medication-assisted treatment (MAT) pharmacy program, which supports patients in recovery from substance use disorder by eliminating many of the barriers to treatment. By reducing stigma and challenges related to transportation and availability of medication, our pharmacy program has seen improved patient outcomes in multiple areas, including a 52% increase in the rate of patients remaining in treatment.

Lastly, Cordant is all in when it comes to the Support Americans by Creating Healthy Environments pillar by offering a behavioral health-focused pharmacy solution that works collaboratively with healthcare providers to offer medications, patient education and services for the treatment of substance use disorder (SUD) as well as co-occurring behavioral health disorders and other complex and chronic conditions, including hepatitis.

In the new year and beyond, we look forward to supporting providers and patients by providing solutions that help make treatment more accessible.